Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 27,295 | 21,576 | 34,107 | 745,118 | 8,343 |
| Cost of Goods | 6,493 | 102 | 128 | 146 | 127 |
| Gross Profit | 20,802 | 21,474 | 33,979 | 744,972 | 8,216 |
| Operating Expenses | 129,806 | 121,814 | 120,072 | 111,751 | 133,380 |
| Operating Income | -108,511 | -100,238 | -85,965 | 633,367 | -125,037 |
| Other Income | 260 | 524 | 986 | 981 | 1,563 |
| Pre-tax Income | -108,251 | -99,714 | -84,979 | 634,348 | -123,474 |
| Income Tax | 193 | N/A | 688 | 370 | N/A |
| Net Income Continuous | -108,444 | -99,714 | -85,667 | 633,978 | -123,474 |
| Net Income | $-108,444 | $-99,714 | $-85,667 | $633,978 | $-123,474 |
| EPS Basic Total Ops | -1.86 | -1.72 | -1.34 | 11.49 | -2.28 |
| EPS Basic Continuous Ops | -1.86 | -1.72 | -1.35 | 11.49 | -2.28 |
| EPS Diluted Total Ops | -1.86 | -1.72 | -1.18 | 11.16 | -2.28 |
| EPS Diluted Continuous Ops | -1.86 | -1.72 | -1.19 | 11.16 | -2.28 |
| EBITDA(a) | $-106,919 | $-98,630 | $-83,827 | $635,015 | $-123,369 |